Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02003183 · ClinicalTrials.gov registry record
Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 24
- Enrollment target
NCT02003183 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 24 participants.
The verdict
NCT02003183 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
This project was designed to determine brain imaging patterns using 2-(1-{6-\[(2-fluorine 18-labeled fluoroethyl)methylamino\]-2-naphthyl}ethylidene)malononitrile (\[F-18\]FDDNP) with positron emission tomography (PET) in participants with suspected Chronic Traumatic Encephalopathy (CTE), a progressive degenerative disease of the brain found in people with a history of repetitive traumatic brain injuries (TBIs), characterized by personality, behavioral, and mood disturbances, cognitive impairment, and sometimes motor symptoms. Currently, CTE can only be definitely diagnosed from neuropathological examination of the brain after autopsy. Developing tools to assist in the detection of this condition in living individuals at risk would facilitate research focusing on discovering potential prevention and treatment strategies.
Interventions
- RADIATION [F-18]FDDNP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-03 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02003183
The ClinicalTrials.gov registry entry for NCT02003183 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [F-18]FDDNP is the first listed.
NCT02003183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02003183 about?
NCT02003183 is a clinical study titled "Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy". This project was designed to determine brain imaging patterns using 2-(1-{6-\[(2-fluorine 18-labeled fluoroethyl)methylamino\]-2-naphthyl}ethylidene)malononitrile (\[F-18\]FDDNP) with positron emission tomography (PET) in participants with suspected Chronic Traumatic Encephalopathy (CTE), a progress...
What is the current status of trial NCT02003183?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2013-03. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02003183?
The interventions under investigation include: [F-18]FDDNP (RADIATION).
Who is sponsoring clinical trial NCT02003183?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.